Rashmi Tondon
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 3
-
- Blood donation and transfusion practices 4
- Biochemistry top 10%
- Blood transfusion and management 2
-
- Genetic factors in colorectal cancer 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
-
- BRCA gene mutations in cancer 3
-
- Liver Disease Diagnosis and Treatment 3
-
- Eosinophilic Esophagitis 2
- Co-authors
- Rajendra ChaudharySusan M. DomchekUrsina TeitelbaumKim A. ReissMark H. O’HaraCharles SchneiderThomas B. KarasicVirginia A. LiVolsi
- Journals
- Journal of Clinical Oncology (1 paper)Gastroenterology (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United StatesIndiaIsrael
In The Last Decade
Rashmi Tondon
29 papers receiving 620 citations
Peers
Comparison fields: 5 of 67
- Oncology 296
- Cancer Research 143
- Management of Technology and Innovation 60
- Biochemistry 49
- Pathology and Forensic Medicine 91
Countries citing papers authored by Rashmi Tondon
This map shows the geographic impact of Rashmi Tondon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rashmi Tondon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rashmi Tondon more than expected).
Fields of papers citing papers by Rashmi Tondon
This network shows the impact of papers produced by Rashmi Tondon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rashmi Tondon. The network helps show where Rashmi Tondon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rashmi Tondon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 3 | |
| 7 | 2020 | 27 | |
| 8 | 2019 | 14 | |
| 9 | 2019 | 4 | |
| 10 | 2018 | 79 | |
| 11 | 2018 | 0 | |
| 12 | 2017 | 21 | |
| 13 | 2017 | 18 | |
| 14 | 2017 | 3 | |
| 15 | 2016 | 2 | |
| 16 | 2010 | 10 | |
| 17 | 2008 | 25 | |
| 18 | 2008 | 27 | |
| 19 | 2008 | 17 | |
| 20 | 2007 | 5 |
About Rashmi Tondon
Rashmi Tondon is a scholar working on Management of Technology and Innovation, Hepatology and Hematology, having authored 33 papers that have together received 630 indexed citations. Recurring topics across this work include Blood donation and transfusion practices (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), BRCA gene mutations in cancer (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Genetic factors in colorectal cancer (3 papers), Eosinophilic Esophagitis (2 papers) and Blood transfusion and management (2 papers). The work is most often cited by research in Oncology (296 citations), Cancer Research (143 citations) and Management of Technology and Innovation (60 citations). Rashmi Tondon has collaborated with scholars based in United States, India and Israel. Frequent co-authors include Rajendra Chaudhary, Susan M. Domchek, Ursina Teitelbaum, Kim A. Reiss, Mark H. O’Hara, Charles Schneider, Thomas B. Karasic, Virginia A. LiVolsi, Prashant Pandey and Robert H. Vonderheide. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.